0001209191-13-056980.txt : 20131213 0001209191-13-056980.hdr.sgml : 20131213 20131213200308 ACCESSION NUMBER: 0001209191-13-056980 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131212 FILED AS OF DATE: 20131213 DATE AS OF CHANGE: 20131213 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SANGAMO BIOSCIENCES INC CENTRAL INDEX KEY: 0001001233 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 680359556 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 501 CANAL BLVD STREET 2: POINT RICHMOND TECH CNTR. CITY: RICHMOND STATE: CA ZIP: 94804 BUSINESS PHONE: 5109706000 MAIL ADDRESS: STREET 1: 501 CANAL BLVD STREET 2: POINT RICHMOND TECH CNTR. CITY: RICHMOND STATE: CA ZIP: 94804 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ANDO DALE G CENTRAL INDEX KEY: 0001202278 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30171 FILM NUMBER: 131277515 MAIL ADDRESS: STREET 1: C/O CELL GENESYS INC STREET 2: 500 FORBES BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2013-12-12 0 0001001233 SANGAMO BIOSCIENCES INC SGMO 0001202278 ANDO DALE G C/O SANGAMO BIOSCIENCES INC. POINT RICHMOND TECH CNTR, 501 CANAL BLVD RICHMOND CA 94804 0 1 0 0 VP, Therapeutic Dev. & CMO Common Stock 2013-12-12 4 A 0 23000 0.00 A 111798 D Common Stock 2013-12-12 4 F 0 14783 12.12 D 97015 D Employee Stock Option (Right to Buy) 12.12 2013-12-12 4 A 0 46000 0.00 A 2023-12-11 Common Stock 46000 46000 D Shares subject to restricted stock units ("RSUs"), which will vest in a series of three successive equal annual installments upon the Reporting Person's completion of each year of service over the three year period from the grant date. Includes 33,333 shares and 23,333 shares subject to RSUs granted on December 8, 2011 and December 6, 2012, respectively, which will be issued as such units vest in accordance with their terms. Represents shares withheld to satisfy the Reporting Person's tax withholding obligation upon the vesting and issuance of RSUs. The stock option vests and becomes exercisable for 25% of the shares upon the Reporting Person's completion of one year of service measured from the grant date, and the balance of the shares will vest and become exercisable in 36 successive equal monthly installments upon his completion of each additional month of service thereafter. /s/ Florence Tam, attorney-in-fact 2013-12-13